Publications Office of the EU
Conclusion of non-exclusive discount agreements according to § 130a(8) SGB V in the period from 01.01.2025 - 30.06.2026 - Public Procurement procedure view
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Conclusion of non-exclusive discount agreements according to § 130a(8) SGB V in the period from 01.01.2025 - 30.06.2026 Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    27/11/2024
  • Today
    05/12/2024
  • Deadline
    10/05/2026
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
GWQ ServicePlus AG
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DEA11 Düsseldorf, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
7
Procedure details
Tender reference number
Not available
Description

Paragraph 130a(8) of the SGB V enables health insurance funds (KK) and pharmaceutical companies to conclude framework discount agreements for the medicinal products to be supplied at the expense of the statutory health insurance companies. GWQ acts as a company for cost-effectiveness and quality at KK in accordance with § 130a(8)(5) SGBV for its shareholder and customer funds. With regard to the relevant statutory provisions on public procurement, a regular process of active substance-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until the entry into force of new drug discount agreements, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies. Contract start date is 01.01.2025. Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Electronic submission: eu.europa.publications.PublicProcurement.electronic.submission.not-allowed
sen-info
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
DE Deutschland
DEA11 Düsseldorf, Kreisfreie Stadt
CPV code

33600000 - Pharmaceutical products

Lots (7)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.